[1]尹晨东,仇湘中△.补肝健腰方对腰椎间盘突出大鼠血清代谢组学的影响研究[J].中国中医骨伤科杂志,2023,31(09):7-14.[doi:10.20085/j.cnki.issn1005-0205.230902 ]
　YIN Chendong,QIU Xiangzhong.Effect of Bugan Jianyao Formula on Serum Metabolomics in Rats with Lumbar Intervertebral Disc Herniation[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2023,31(09):7-14.[doi:10.20085/j.cnki.issn1005-0205.230902 ]
点击复制

补肝健腰方对腰椎间盘突出大鼠血清代谢组学的影响研究()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第31卷
期数:
2023年09期
页码:
7-14
栏目:
实验研究
出版日期:
2023-09-15

文章信息/Info

Title:
Effect of Bugan Jianyao Formula on Serum Metabolomics in Rats with Lumbar Intervertebral Disc Herniation
文章编号:
1005-0205(2023)09-0007-08
作者:
尹晨东1; 仇湘中2△
1湖南中医药高等专科学校(湖南 株洲,412012) 2湖南省中医药研究院附属医院
Author(s):
YIN Chendong1; QIU Xiangzhong2△
1Hunan College of Traditional Chinese Medicine,Zhuzhou 412012,Hunan China; 2Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine,Changsha 410006,China.
关键词:
补肝健腰方;  腰椎间盘突出大鼠模型;  代谢组学
Keywords:
Bugan Jianyao decoction;  rat model of lumbar intervertebral disc herniation;  metabolomics
分类号:
R-33
DOI:
10.20085/j.cnki.issn1005-0205.230902
文献标志码:
A
摘要:
目的:探讨补肝健腰方对腰椎间盘突出大鼠模型血清代谢组学的影响。方法:将60只大鼠按随机数字表法,分为正常组12只、假手术组12只、造模组36只。造模组36只大鼠进行自身尾椎椎间盘移植法腰椎间盘突出模型(L5/6)造模处理,假手术组只暴露L5神经根,不给予自体尾椎椎间盘移植。对造模后进行神经功能评分及观察其行为学改变,造模成功后,将造模组分为模型组、中剂量组、高剂量组,每组12只,并进行中药干预。其中中、高剂量组分别给予补肝健腰方中、高剂量汤剂灌胃,正常组、模型组、假手术组,给予等剂量生理盐水灌胃。分别于干预后第1,2,3周采集大鼠腹主动脉血清进行代谢组学分析,回收包埋在L5神经根处的尾椎椎间盘标本,HE染色后用光学显微镜下对标本进行组织形态学观察。结果:通过自体尾椎椎间盘移植法成功造出腰椎间盘突出模型,血清中共筛选出多种代谢差异物,对筛选出的谷氨酸、乳酸进行分析,发现腰椎间盘突出大鼠模型血清中谷氨酸、乳酸发生了动态变化。造模后大鼠腰椎间盘组织在药物干预后第1,2,3周镜下观察均在呈现不同程度的形态学改变,补肝健腰方中、高剂量组均在干预后第3周镜下观察大鼠腰椎间盘突出组织较之前得到改善。结论:补肝健腰方通过对大鼠血清中谷氨酸、乳酸的影响,对腰椎间盘突出具有干预作用,可能是补肝健腰方治疗腰椎间盘突出症的机制之一。
Abstract:
Objective:To investigate the effect of bugan jianyao decoction on serum metabolomics of rats with lumbar disc herniation.Methods: 60 rats were randomly divided into normal group(12 rats),sham operation group(12 rats)and model group(36 rats).In the model group,36 rats were treated with lumbar disc herniation model(L5/6)by autologous caudal intervertebral disc transplantation.In the sham operation group,only L5 nerve root was exposed,and autologous caudal intervertebral disc transplantation was not given.After the establishment of the model,the neurological function score and the behavioral changes were observed.After the establishment of the model,the model group was divided into model group,medium dose group and high dose group,with 12 rats in each group,and the intervention of traditional Chinese medicine was carried out.The medium and high dose groups were given the medium and high dose decoction of bugan jianyao decoction by gavage,and the normal group,model group and sham operation group were given the same dose of normal saline by gavage.At the 1st,2nd and 3rd week after intervention,the serum of rat abdominal aorta was collected for metabonomic analysis,and the specimens of caudal intervertebral disc embedded in L5 nerve root were recovered.After hematoxylin-eosin(HE)staining,the specimens were observed under optical microscope for histomorphology.Results:The lumbar intervertebral disc herniation model was successfully created by the rat autologous coccygeal intervertebral disc transplantation method.A variety of metabolic differences were screened in the serum,and the screened glutamic acid and lactic acid were analyzed.It was found that the serum glutamic acid and lactic acid changed dynamically in the rat model of lumbar disc herniation.After modeling,the lumbar intervertebral disc tissue of rats showed different degrees of morphological changes under the microscope at 1st,2nd and 3rd week after the drug intervention.It was observed that the herniated tissue of the lumbar intervertebral disc of the rat was improved compared with before.Conclusion:Bugan Jianyao decoction has an intervention effect on lumbar intervertebral disc herniation through the effect of glutamic acid and lactic acid in serum of rats,which may be one of the mechanisms of bugan jianyao decoction on the treatment of lumbar intervertebral disc herniation.

参考文献/References:

[1] 中华医学会疼痛学分会脊柱源性疼痛学组.腰椎间盘突出症诊疗中国疼痛专家共识[J].中国疼痛医学杂志,2020,26(1):2-6.
[2] 袁清照,胥骞,杨莹,等.名老中医仇湘中验方补肝健腰方的制剂研究[J].湖南中医杂志,2022,38(3):175-179.
[3] 仇杰,仇湘中,蒋盛昶,等.补肝通络法内外并治腰椎间盘源性腰痛60例临床观察[J].湖南中医杂志,2019,35(2):58-60.
[4] 仇湘中,朱承勋,张信成,等.补肝健腰方对腰椎间盘退变大鼠椎间盘TNF-α及NF-κB表达的影响[J].中国中医骨伤科杂志,2017,25(9):9-11.
[5] SHAN L,LIAO F,JIN H,et al.Plasma metabonomic profiling of lumbar disc herniation and its traditional Chinese medicine subtypes in patients by using gas chromatography coupled with mass spectrometry[J].Mol Biosyst,2014,10(11):2965-2973.
[6] 杨树彬,刘勇,于涛.基于GC-MS的LDH模型兔血浆代谢组学研究[J].齐鲁医学杂志,2016,31(3):307-309.
[7] 程帅,陈伯华,刘勇,等.基于GC-TOF-MS的兔退变椎间盘代谢轮廓分析[J].齐鲁医学杂志,2016,31(2):181-183.
[8] 丁欢,陈丽虹,陈宇婧,等.基于尿液代谢组学数据评价不同刮痧方案干预腰椎间盘突出症模型大鼠的效果[J].中国组织工程研究,2019,23(23):3654-3659.
[9] 陈丽虹,岳容兆,张永怡,等.刮痧治疗腰椎间盘突出症不同方案疗效差异:基于血清代谢组学的评价[J].中国组织工程研究,2018,22(32):5110-5116.
[10] JIANG R,XU G,CHEN H,et al.Effect of scraping therapy on interleukin-1 in serum of rats with lumbar disc herniation[J].J Tradit Chin Med,2013,33(1):109-113.
[11] 师振予,郭亦杰,曾嵘,等.腰椎间盘突出症大鼠模型的建立及病理动态研究[J].湖南中医药大学学报,2020,40(1):28-33.
[12] 赵彩萍,朱美玲,王婷婷,等.化学神经根炎症模型大鼠的制备及评价[J].中国组织工程研究,2019,23(7):1030-1034.
[13] 黄继汉,黄晓晖,陈志扬,等.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004(9):1069-1072.
[14] 安文博,姜劲挺,张伦广,等.复方倍他米松局部注射后自体髓核移植模型大鼠脊髓及背根神经节中P物质和降钙素基因相关肽变化[J].中国组织工程研究,2014,18(49):7955-7960.
[15] SIEGAL T,SHOHAMI E,SHAPIRA Y,et al.Indomethacin and dexamethasone treatment in experimental neoplastic spinal cord compression:Part 2.Effect on edema and prostaglandin synthesis[J].Neurosurgery,1988,22(2):334-339.
[16] 黄振星,杨少锋,郭彦涛,等.恒古骨伤愈合剂治疗瘀血阻络型腰椎间盘突出症的临床疗效[J].中国中医骨伤科杂志,2022,30(3):35-38.
[17] 刘锦涛,俞鹏飞,马智佳,等.巨大破裂型腰椎间盘突出症重吸收55例分析[J].中国中医骨伤科杂志,2021,29(9):27-31.
[18] STRÖMQVIST F,STRÖMQVIST B,JÖNSSON B,et al.Surgical treatment of lumbar disc herniation in different ages-evaluation of 11,237 patients[J].Spine J,2017,17(11):1577-1585.
[19] JORDAN J,KONSTANTINOU K,DOWD J.Herniated lumbar disc[J].BMJ Clin Evid,2009:1118.
[20] 林承宇,张清,谢瑞,等.腰椎间盘突出症合并神经根病变的诊疗:NASS循证医学指南解读[J].海南医学院学报,2019,25(22):1745-1751.
[21] DEYO R A,MIRZA S K.Herniated lumbar intervertebral disk[J].N Engl J Med,2016,374(18):1763-1772.
[22] 刘宗玮,温剑涛,张德宏,等.腰椎间盘突出症椎间盘退变相关炎性因子研究进展[J].中医药临床杂志,2019,31(2):388-391.
[23] 曾佳兴,梁斌.腰椎间盘突出发病机制的研究进展[J].医学综述,2012.18(11):1723-1726.
[24] 陈锋,吴晓飞,闫乾,等.腰椎间盘突出症中医证候学研究[J].辽宁中医药大学学报,2019,21(12):13-16.
[25] 王建平.近5年腰椎间盘突出症的中医治疗综述[J].中医临床研究,2020,12(19):143-145.
[26] 姚新苗,周国庆.从“以筋为主”的视角认识现代脊柱康复医学[J].康复学报,2015,25(4):52-55.
[27] HUETTNER J E.Glutamate receptor channels in rat DRG neurons:activation by kainate and quisqualate and blockade of desensitization by Con A[J].Neuron,1990,5(3):255-266.
[28] ADAMS M A,ROUGHLEY P J.What is intervertebral disc degeneration,and what causes it?[J].Spine(Phila Pa 1976),2006,31(18):2151-2161.
[29] HARRINGTON J F,MESSIER A A,BEREITER D,et al.Herniated lumbar disc material as a source of free glutamate available to affect pain signals through the dorsal root ganglion[J].Spine(Phila Pa 1976),2000,25(8):929-936.
[30] 李若禹,丁文元.磁共振影像标志物对椎间盘退变及盘源性下腰痛诊断的研究进展[J].中华骨科杂志,2020,40(13):880-888.
[31] 潘化平,王健,冯慧,等.腰椎间盘突出症的疼痛发生机制与治疗进展[J].海南医学院学报,2008,14(6):761-764.
[32] 胡星新,刘立岷.临床症状体征与影像学检查分离的腰椎间盘突出症的发生机制研究进展[J].中国骨伤,2015,28(10):970-975.

备注/Memo

备注/Memo:
基金项目:国家中医药管理局“全国名老中医药专家仇湘中传承工作室建设项目”(国中医药人教发〔2016〕42号)
湖南省研究生科研创新项目(CX20200776)
湖南中医药高等专科学校校级科研计划项目(XY2022.002)
△通信作者 E-mail:18974991366@189.cn
更新日期/Last Update: 2023-09-01